These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4590994)

  • 21. Characteristics of some co-trimoxazole-resistant Enterobacteriaceae from infected patients.
    Barker J; Healing D; Hutchison JG
    J Clin Pathol; 1972 Dec; 25(12):1086-8. PubMed ID: 4570620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro resistance of haemophilus influenzae to co-trimoxazole and trimethoprim.
    Cornere BM; Menzies R
    N Z Med J; 1975 Mar; 81(536):292-4. PubMed ID: 1079587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity testing with trimethorpim-sulphamethoxazole.
    Bushby SR
    Med J Aust; 1973 Jun; 1(2):Suppl:10-8. PubMed ID: 4199527
    [No Abstract]   [Full Text] [Related]  

  • 24. Proceedings: Further thoughts on sulphonamide-trimethoprim mixtures.
    Lacey RW; Lewis EL; Anderson JD
    J Clin Pathol; 1974 Jun; 27(6):512. PubMed ID: 4415266
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of co-trimoxazole on faecal enterobacteria: no emergence of resistant strains.
    Moorhouse EC; Farrell W
    J Med Microbiol; 1973 May; 6(2):249-52. PubMed ID: 4575275
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined action of sulphamethoxazole and trimethoprim against clinically-isolated sulphonamide-resistant bacteria.
    Grey D; Hamilton-Miller JM; Brumfitt W
    Chemotherapy; 1979; 25(5):296-302. PubMed ID: 383418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance to trimethoprim in Klebsiellae isolated before its introduction.
    Hamilton-Miller JM; Grey D
    J Antimicrob Chemother; 1975 Jun; 1(2):213-8. PubMed ID: 1100591
    [No Abstract]   [Full Text] [Related]  

  • 28. The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole.
    Küchler R; Koch UJ
    Chemotherapy; 1973; 18(4):242-52. PubMed ID: 4571975
    [No Abstract]   [Full Text] [Related]  

  • 29. Co-trimoxazole resistance in Jamaica.
    Macfarlane DE
    Lancet; 1986 Apr; 1(8486):923. PubMed ID: 2870396
    [No Abstract]   [Full Text] [Related]  

  • 30. Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.
    Fruensgaard K; Korner B
    Chemotherapy; 1974; 20(2):97-101. PubMed ID: 4210895
    [No Abstract]   [Full Text] [Related]  

  • 31. Epidemic Shigella sonnei resistant to co-trimoxazole.
    Pérez Trallero E; López Lopatequi C; Jiménez Alfaro JA; García Arenzana JM
    Lancet; 1981 Oct; 2(8249):751. PubMed ID: 6116883
    [No Abstract]   [Full Text] [Related]  

  • 32. Do sulphonamide-trimethoprim combinations select less resistance to trimethoprim than the use of trimethoprim alone?
    Lacey RW
    J Med Microbiol; 1982 Nov; 15(4):403-27. PubMed ID: 6294297
    [No Abstract]   [Full Text] [Related]  

  • 33. Bactericidal activity of trimethoprim alone and in combination with sulfamethoxazole on susceptible and resistant Escherichia coli K-12.
    Amyes SG
    Antimicrob Agents Chemother; 1982 Feb; 21(2):288-93. PubMed ID: 7041815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of non-epidemic Shigella sonnei resistant to co-trimoxazole.
    Palenque E; Otero JR; Noriega AR
    J Antimicrob Chemother; 1983 Feb; 11(2):196-8. PubMed ID: 6339462
    [No Abstract]   [Full Text] [Related]  

  • 35. Kinetics and mechanisms of action of trimethoprim and sulfonamides, alone or in combination, upon Escherichia coli.
    Seydel JK; Wempe E; Miller GH; Miller L
    Chemotherapy; 1972; 17(4):217-58. PubMed ID: 4557279
    [No Abstract]   [Full Text] [Related]  

  • 36. Synergy of trimethoprim-sulfamethoxazole.
    Bushby SR
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):63-6. PubMed ID: 1093654
    [No Abstract]   [Full Text] [Related]  

  • 37. Letter: Co-trimoxazole resistance.
    Okubadejo OA; Maskell RM
    Br Med J; 1974 Apr; 2(5912):227. PubMed ID: 4598861
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antibiotic susceptibility of E. coli strains isolated from urinary tract infections and the role of metabolically deficient strains in these infections].
    Söyletir G; Günalp A
    Mikrobiyol Bul; 1985 Oct; 19(4):210-7. PubMed ID: 3913849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
    Murray BE; Rensimer ER; DuPont HL
    N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial resistance to trimethoprim-sulfamethoxazole.
    N Engl J Med; 1982 Jul; 307(1):60-2. PubMed ID: 7043275
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.